Published online June 1, 2005
PEDIATRICS Vol. 115 No. 6 June 2005, pp. 1666-1674 (doi:10.1542/peds.2004-1979)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Powers, K. S.
Right arrow Articles by Rubenstein, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Powers, K. S.
Right arrow Articles by Rubenstein, J. S.
Related Collections
Right arrow Therapeutics & Toxicology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Bispectral Index as a Guide for Titration of Propofol During Procedural Sedation Among Children

Karen S. Powers, MD, Emily B. Nazarian, MD, Sarah A. Tapyrik, MD, Susan M. Kohli, MD, Hsiang Yin, MD, Elise W. van der Jagt, MD, MPH, John S. Sullivan, MD and Jeffrey S. Rubenstein, MD, MBA

From the Division of Pediatric Critical Care, Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York

Objective. To determine whether the bispectral index (BIS) monitor could be used to guide physicians in titrating propofol to an effective safe level of deep sedation for children undergoing painful medical procedures.

Design. Multiphase clinical trial.

Setting. Outpatient treatment center of a university children's hospital.

Patients. Pediatric outpatients undergoing painful medical procedures.

Interventions. Patients were sedated with propofol for the procedures. Patients were monitored with a BIS monitor, and the BIS score was correlated with the patient's clinical level of sedation. The BIS score was then used as a guide to titrate propofol in the last phase of the study.

Measurements and Main Results. The study consisted of 3 phases. In a chart review of data for 154 children who underwent 212 procedures, propofol was found to be safe and effective, with consistent dosing among the intensivists administering the medication. The children received a mean bolus dose of propofol of 1.56 mg/kg, with a mean total dose of propofol of 0.33 mg/kg per minute for the duration of the procedure. In the second phase, 21 patients ranging in age from 27 weeks to 18 years, with normal neurologic function, were sedated with propofol. An observer who was blinded to the BIS scores recorded clinical levels of sedation and reactivity (with a modified Ramsay scale and reactivity score) every 1 to 3 minutes. Another observer recorded the BIS scores at the same times. A total of 275 data points were collected and evaluated. All data points from the times at which patients were considered to be sedated adequately were used to construct a normal distribution of BIS scores. The mean BIS score was 62. This distribution was used to predict that a maximal BIS score of 47 was needed to ensure adequate sedation for 90% of the population. In the third phase of the study, an algorithm was devised to determine the target BIS score necessary for adequate sedation of 95% of the patients. We chose an initial BIS score of 50 (at which 85% of the patients in phase 2 were sedated) because of the possibility of data from phase 2 being skewed toward oversedation. Propofol was administered by an intensivist in an attempt to maintain the target BIS score. A blinded observer noted the patient's clinical level of sedation. In this group, there were 2 failures, ie, patients were clinically uncomfortable despite a BIS score of ≤50, representing only 90% success. Therefore, with the algorithm, propofol was titrated to sedate the next patients to a BIS score of 45. These patients required a mean bolus dose of 1.47 mg/kg and a mean total dose of 0.51 mg/kg per minute to maintain a BIS score of 45. They awakened in 12.75 minutes. All patients were sedated adequately, all procedures were successful, and no patients experienced complications from the sedation. To eliminate variability in the way propofol was dosed, the next 10 patients were given propofol according to a standardized protocol. These 10 children received an initial bolus of 1 mg/kg, with incremental bolus doses of 0.5 mg/kg per dose (maximum: 20 mg) to achieve and to maintain a BIS score of 45. With this protocol, all patients were sedated adequately and none experienced complications from the sedation. The patients required a mean bolus dose of 2.23 mg/kg and a mean dose of 0.52 mg/kg per minute to maintain a BIS score of 45. The mean time until awakening was 14.9 minutes. Regarding the total dose over time and the time until awakening, there was no statistical significance between this group and the group sedated to a BIS score of 45 without the dosing protocol.

Conclusion. The BIS monitor can be a useful monitoring guide for the titration of propofol by physicians who are competent in airway and hemodynamic management, to achieve deep sedation for children undergoing painful procedures.


Key Words: bispectral index monitor • propofol • deep sedation • pediatrics • outpatient procedures • painful procedures • procedural sedation

Abbreviations: BIS, bispectral index


Accepted Nov 16, 2004.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
A. Lamas, J. Lopez-Herce, L. Sancho, S. Mencia, A. Carrillo, M. J. Santiago, and V. Martinez
Assessment of the level of sedation in children after cardiac surgery.
Ann. Thorac. Surg., July 1, 2009; 88(1): 144 - 150.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. Munte, J. Klockars, M. van Gils, A. Hiller, M. Winterhalter, C. Quandt, M. Gross, and T. Taivainen
The Narcotrend Index Indicates Age-Related Changes During Propofol Induction in Children
Anesth. Analg., July 1, 2009; 109(1): 53 - 59.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
J. D. Tobias
Bispectral Index Monitoring Documents Burst Suppression During Pentobarbital Coma
J Intensive Care Med, July 1, 2008; 23(4): 258 - 262.
[Abstract] [PDF]


Home page
RadiologyHome page
S. E. Zgleszewski, D. Zurakowski, P. J. Fontaine, M. D'Angelo, and K. P. Mason
Is Propofol a Safe Alternative to Pentobarbital for Sedation during Pediatric Diagnostic CT?
Radiology, May 1, 2008; 247(2): 528 - 534.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Lamas, J. Lopez-Herce, L. Sancho, S. Mencia, A. Carrillo, M. J. Santiago, and V. Martinez
Bispectral Index and Middle Latency Auditory Evoked Potentials in Children Younger Than Two-Years-Old
Anesth. Analg., February 1, 2008; 106(2): 426 - 432.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
O. Tirel, E. Wodey, R. Harris, J. Y. Bansard, C. Ecoffey, and L. Senhadji
Variation of bispectral index under TIVA with propofol in a paediatric population
Br. J. Anaesth., January 1, 2008; 100(1): 82 - 87.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. Malviya, T. Voepel-Lewis, A. R. Tait, M. F. Watcha, S. Sadhasivam, and R. H. Friesen
Effect of Age and Sedative Agent on the Accuracy of Bispectral Index in Detecting Depth of Sedation in Children
Pediatrics, September 1, 2007; 120(3): e461 - e470.
[Abstract] [Full Text] [PDF]